Hide Studies Not Open or Pending
Condition(s):FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 3 Endometrial Endometrioid AdenocarcinomaLast Updated:November 16, 2021Completed
Condition(s):Ovarian Neoplasms; Endometrial Neoplasms; Breast Neoplasms; Gonadal Disorders; Uterine DiseasesLast Updated:April 20, 2020Completed
Condition(s):Endometrial CancerLast Updated:January 25, 2019Unknown status
Condition(s):Endometrial CancerLast Updated:May 30, 2023Not yet recruiting
Condition(s):Ovarian Neoplasms; Endometrial Neoplasms; Endometrial Cancer; Ovarian Cancer; Screening; Safety; Reduced Mortality; Reduced Morbidity; Early DiagnosisLast Updated:March 14, 2023Recruiting
Condition(s):Endometrial CancerLast Updated:May 19, 2021Completed
Condition(s):Metastatic Endometrial CancerLast Updated:April 7, 2023Active, not recruiting
Condition(s):Endometrial Cancer; Extreme ObesityLast Updated:February 11, 2020Completed
Condition(s):Gynecologic Cancer; Cancer Metastatic; Ovarian Neoplasms; Cervical Neoplasm; Endometrial NeoplasmsLast Updated:October 12, 2022Active, not recruiting
Condition(s):Endometrial Cancer; Gynecological CancersLast Updated:November 17, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.